Showing 7,321 - 7,340 results of 31,582 for search '(( a step decrease ) OR ( 50 ((((we decrease) OR (nn decrease))) OR (a decrease)) ))', query time: 0.94s Refine Results
  1. 7321
  2. 7322
  3. 7323
  4. 7324
  5. 7325
  6. 7326
  7. 7327
  8. 7328

    Percentage positive tests, tests turnaround times (24h-48h) and cumulative cases are reported from March 17, 2020 to November 28, 2020 in Toronto. by Elena Aruffo (11981366)

    Published 2022
    “…<p>The percentage positive tests decrease from May 31 to August 24, when it starts increasing, showing, however a magnitude smaller than the first wave in March. …”
  9. 7329

    Pyridoxine chlorhydrate forced degradation. by Marine Bonino (21156835)

    Published 2025
    “…In compounding practice, a medication can be done extemporaneously, leading to a risk of error. …”
  10. 7330

    Thiamine chlorhydrate forced degradation. by Marine Bonino (21156835)

    Published 2025
    “…In compounding practice, a medication can be done extemporaneously, leading to a risk of error. …”
  11. 7331

    Riboflavine forced degradation. by Marine Bonino (21156835)

    Published 2025
    “…In compounding practice, a medication can be done extemporaneously, leading to a risk of error. …”
  12. 7332

    Biotin forced degradation. by Marine Bonino (21156835)

    Published 2025
    “…In compounding practice, a medication can be done extemporaneously, leading to a risk of error. …”
  13. 7333
  14. 7334

    Characteristics of dexmedetomidine use. by Shi-Yuan Yu (17054536)

    Published 2023
    “…Forty-five percent of patients had ≥50% days of rousable sedation. Hypotension occurred in 85% of patients. …”
  15. 7335

    Baseline characteristics. by Shi-Yuan Yu (17054536)

    Published 2023
    “…Forty-five percent of patients had ≥50% days of rousable sedation. Hypotension occurred in 85% of patients. …”
  16. 7336
  17. 7337

    Effect of BNN27 treatment on stride length and width in male and female mice. by Kelly E. Glajch (3204465)

    Published 2016
    “…<p>Male Tg vehicle-treated mice exhibited a decrease in stride length (a, left) at p115 (p = 0.0136, Mann-Whitney <i>U</i> test) and stride width (b, left) at p95 (p = 0.0202, Mann-Whitney <i>U</i> test) relative to Wt vehicle-treated mice. …”
  18. 7338
  19. 7339
  20. 7340